Market Overview

Dicerna Pharmaceuticals (NASDAQ: DRNA)

13.99 +0.49 (3.63%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/06/18B. Riley FBRUpgradesBuy21.0
10/30/18CitigroupMaintainsBuy30.0
9/17/18B. Riley FBRMaintainsNeutral13.5
9/13/18CitigroupInitiates Coverage OnBuy27.0
8/15/18H.C. WainwrightUpgradesBuy0.0
8/09/18Stifel NicolausMaintainsBuy20.0
3/28/18B. Riley FBRInitiates Coverage OnNeutral10.0
3/23/18H.C. WainwrightDowngradesNeutral
3/09/18Stifel NicolausMaintainsBuy17.0
2/05/18SunTrust Robinson HumphreyInitiates Coverage OnBuy13.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter